Skip to main content
See every side of every news story
Published • loading... • Updated

Who should take GLP-1s? — Harvard Gazette

Health ‘Harvard Thinking’: Who should take GLP-1s? Samantha Laine Perfas Harvard Staff Writer October 21, 2026 long read Experts dig into what we’ve overlooked in rush to embrace ‘magical’ weight-loss drugs GLP-1s were created to treat Type 2 diabetes. But since their discovery as a tool for fighting obesity, they have surged in popularity. As of last year, nearly one in eight American adults were …

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Harvard University broke the news in Harvard, United States on Wednesday, October 21, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal